{
    "clinical_study": {
        "@rank": "90582", 
        "acronym": "T2DM", 
        "arm_group": {
            "arm_group_label": "gastric bypass, duodenojejunal bypass", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Surgical treatment for type 2 diabetes has been taken note especially in less obese or non\n      obese patients. In Asian, the nuber of less obses or non obese patients with T2DM is greater\n      than that of the obese.\n\n      We are trying to do a prospective observational study for the evaluation of the effect of\n      duidenojejunal bypass and gastric bypass on the glycemoc control in those patients.\n\n      The selection criteria are type 2 diabetess, 20-60 years old, BMI 23-34 or 21-22 with\n      viceral obesity, insulin use less than 10 years and the patients understanding the\n      hypothesis of this study, risks, expecting effects and agreeing this study.\n\n      We are checking oral GTT, insulin level, C-peptide level, HbA1C, etc. with some\n      anthropometric measurs preoperatively, postoperatively, at 3 month and 12 month.\n\n      We will compare the clinical factors at each time."
        }, 
        "brief_title": "Prospective Observatonal Study for Effect of Duodenojejunal Bypass and Gastric Bypass on T2DM Patients", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Non Insulin Dependent Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  type 2 diabetes\n\n          -  HbA1C > 7.0%\n\n          -  BMI 23 - 34 or BMI 21-22 with viceral obesity\n\n          -  insulin use less than 10 years\n\n          -  uncerstanding the risks, hypothesis, expecting effects\n\n        Exclusion Criteria:\n\n          -  type 1 diabetes\n\n          -  C-peptide < 1.0ng/ml\n\n          -  BMI < 21\n\n          -  severe cardiovascular diseases or their history\n\n          -  malignancy or history\n\n          -  alcoholics, pituitary failrue\n\n          -  history of severe ketosis, diabetic coma or precoma\n\n          -  abnormal liver enzyme, over 3 fold of normal level\n\n          -  liver cirrhosis or hepatitis\n\n          -  serum creatinine > 2.0mg/dL\n\n          -  glucocorticoids user\n\n          -  diabetes due to other endocrine diseases\n\n          -  pancreatic disease\n\n          -  anti-GAD Ab (+)\n\n          -  the incongruity for surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01735253", 
            "org_study_id": "inha 09-58"
        }, 
        "intervention": {
            "arm_group_label": "gastric bypass, duodenojejunal bypass", 
            "description": "routine GBP with 80cm roux and biliopancreatic limb", 
            "intervention_name": "laparoscopic roux en Y gastric bypass / open duodenojejunal bypass", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "metabolic surgery", 
            "gastric bypass", 
            "duodenojejunal bypass", 
            "type 2 DM"
        ], 
        "lastchanged_date": "November 27, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of", 
                    "zip": "400-712"
                }, 
                "name": "Yoonseok Heo"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Metabolic Surgery for Type 2 Diabetes", 
        "other_outcome": {
            "description": "change the levels", 
            "measure": "insulin level", 
            "safety_issue": "Yes", 
            "time_frame": "preoperatively, postoperatively, at 3 month, at 12 month"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "change of the level", 
            "measure": "Hemoglobin A1C", 
            "safety_issue": "Yes", 
            "time_frame": "preoperatively, at 3month, at 12 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01735253"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inha University Hospital", 
            "investigator_full_name": "Inha University Hospital", 
            "investigator_title": "IRB Inha University Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "changes of the level at each time", 
            "measure": "oral glucose tolerance test", 
            "safety_issue": "Yes", 
            "time_frame": "preopertively, postoperatively, at 3 month, at 12 month"
        }, 
        "source": "Inha University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inha University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}